Market Tracker

05/22 6:01pm ET

Anacor Pharmaceuticals Inc (NASDAQ:ANAC)

65.36
Delayed Data
As of May 22
 +1.94 / +3.06%
Today’s Change
13.19
Today|||52-Week Range
68.90
+102.67%
Year-to-Date

Today’s Trading

Previous close63.42
Today’s open63.51
Day’s range63.51 - 66.59
Volume643,575
Average volume (3 months)699,354
Market cap$2.9B
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-198.10%
Earnings growth (this year)+44.14%
Earnings growth (next 5 years)+67.00%
Revenue growth (last year)+20.07%
P/E ratioNM
Price/Sales65.86
Price/Book35.88

Competitors

 Today’s
change
Today’s
% change
RAREUltragenyx Pharmaceu...-1.76-2.07%
CBPOChina Biologic Produ...+1.37+1.27%
WXWuXi PharmaTech (Cay...-0.13-0.30%
CLVSClovis Oncology Inc+0.23+0.25%
Data as of 4:02pm ET, 05/22/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$20.7M
Annual profit (last year)-$87.1M
Net profit margin-421.28%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Paul L. Berns
Chief Financial Officer &
Executive Vice President
Geoffrey M. Parker
Corporate headquarters
Palo Alto, California

Forecasts